Access the full text.
Sign up today, get DeepDyve free for 14 days.
Y.‐J. Hu, S. I. Berndt, S. Gustafsson, A. Ganna, J. Hirschhorn, K. E. North (2013)
Meta‐analysis of gene‐level associations for rare variants based on single‐variant statistics, 93
S. Monga (2011)
Role of Wnt/β-catenin signaling in liver metabolism and cancer.The international journal of biochemistry & cell biology, 43 7
Jianping Sun, Yingye Zheng, L. Hsu (2013)
A Unified Mixed‐Effects Model for Rare‐Variant Association in Sequencing StudiesGenetic Epidemiology, 37
F. Michor, K. Polyak (2010)
The Origins and Implications of Intratumor HeterogeneityCancer Prevention Research, 3
W. Tang, C. Schwienbacher, L. M. Lopez, Y. Ben‐Shlomo, T. Oudot‐Mellakh, A. D. Johnson (2012)
Genetic associations for activated partial thromboplastin time and prothrombin time, their gene expression profiles, and risk of coronary artery disease, 91
Q. Yang, H. Wu, C.‐Y. Guo, C. S. Fox (2010)
Analyze multivariate phenotypes in genetic association studies by combining univariate association tests, 34
S. Lee, M. C. Wu, X. Lin (2012)
Optimal tests for rare variant effects in sequencing association studies, 13
R. Burrell, C. Swanton (2014)
Tumour heterogeneity and the evolution of polyclonal drug resistanceMolecular Oncology, 8
H. Liu, Y. Tang, H. H. Zhang (2009)
A new chi‐square approximation to the distribution of non‐negative definite quadratic forms in non‐central normal variables, 53
Z. Zhuang, Chunzhang Yang, F. Lorenzo, M. Merino, T. Fojo, E. Kebebew, V. Popović, C. Stratakis, J. Prchal, K. Pacak (2012)
Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia.The New England journal of medicine, 367 10
K. Schulze, S. Imbeaud, E. Letouzé, L. Alexandrov, J. Calderaro, S. Rebouissou, G. Couchy, C. Meiller, Jayendra Shinde, F. Soysouvanh, Anna-Line Calatayud, R. Pinyol, L. Pelletier, C. Balabaud, A. Laurent, J. Blanc, V. Mazzaferro, F. Calvo, A. Villanueva, J. Nault, P. Bioulac-Sage, M. Stratton, J. Llovet, J. Zucman‐Rossi (2015)
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targetsNature genetics, 47
E. Lai, S.‐T. Fan, C.‐M. Lo, K.‐M. Chu, C.‐L. Liu, J. Wong (1995)
Hepatic resection for hepatocellular carcinoma. an audit of 343 patients, 221
Computational Statistics and Data Analysis
R. Davies (1977)
Hypothesis testing when a nuisance parameter is present only under the alternativeBiometrika, 74
Yuexin Liu, M. Yasukawa, Kexin Chen, Limei Hu, R. Broaddus, L. Ding, E. Mardis, P. Spellman, D. Levine, G. Mills, I. Shmulevich, A. Sood, Wei Zhang (2015)
Association of Somatic Mutations of ADAMTS Genes With Chemotherapy Sensitivity and Survival in High-Grade Serous Ovarian Carcinoma.JAMA oncology, 1 4
M. C. Wu, S. Lee, T. Cai, Y. Li, M. Boehnke, X. Lin (2011)
Rare‐variant association testing for sequencing data with the sequence kernel association test, 89
M. Ferreira, S. Purcell (2009)
A multivariate test of associationBioinformatics, 25 1
A. Martin, M. E. Ochagavia, L. C. Rabasa, J. Miranda, J. Fernandez‐de Cossio, R. Bringas (2010)
Bisogenet: A new tool for gene network building, visualization and analysis, 11
P. Rachakonda, Andrea Bauer, Huaping Xie, D. Campa, C. Rizzato, F. Canzian, S. Beghelli, W. Greenhalf, Eithne Costello, M. Schanné, A. Heller, A. Scarpa, J. Neoptolemos, J. Werner, M. Büchler, J. Hoheisel, K. Hemminki, N. Giese, Rajiv Kumar (2013)
Somatic Mutations in Exocrine Pancreatic Tumors: Association with Patient SurvivalPLoS ONE, 8
E. Lai, S. Fan, C. Lo, K. Chu, Chi-leung Liu, J. Wong (1995)
Hepatic Resection for Hepatocellular Carcinoma An Audit of 343 PatientsAnnals of Surgery, 221
B. Reva, Yevgeniy Antipin, C. Sander (2011)
Predicting the functional impact of protein mutations: application to cancer genomicsNucleic Acids Research, 39
C. Swanton (2012)
Intratumor heterogeneity: evolution through space and time.Cancer research, 72 19
Y. Ikeda, M. Shimada, H. Hasegawa, T. Gion, K. Kajiyama, K. Shirabe, K. Yanaga, K. Takenaka, K. Sugimachi (1998)
Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resectionHepatology, 27
Seunggeun Lee, Michael Wu, Xihong Lin (2012)
Optimal tests for rare variant effects in sequencing association studies.Biostatistics, 13 4
M. S. Lawrence, P. Stojanov, P. Polak, G. V. Kryukov, K. Cibulskis (2013)
Mutational heterogeneity in cancer and the search for new cancer‐associated genes, 499
A. Petitjean, M. Achatz, A. Børresen-Dale, P. Hainaut, M. Olivier (2007)
TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomesOncogene, 26
A. Petitjean, M. Achatz, A. Borresen‐Dale, P. Hainaut, M. Olivier (2007)
Tp53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes, 26
Weihong Tang, C. Schwienbacher, Lorna Lopez, Y. Ben-Shlomo, Tiphaine Oudot-Mellakh, Andrew Johnson, N. Samani, S. Basu, M. Gögele, G. Davies, G. Lowe, D. Tregouet, Adrian Tan, J. Pankow, A. Tenesa, D. Levy, C. Volpato, A. Rumley, A. Gow, C. Minelli, J. Yarnell, D. Porteous, J. Starr, J. Gallacher, E. Boerwinkle, P. Visscher, P. Pramstaller, M. Cushman, V. Emilsson, A. Plump, N. Matijevic, P. Morange, I. Deary, A. Hicks, A. Folsom (2012)
Genetic associations for activated partial thromboplastin time and prothrombin time, their gene expression profiles, and risk of coronary artery disease.American journal of human genetics, 91 1
A. Maity, P. F. Sullivan, J.‐Y. Tzeng (2012)
Multivariate phenotype association analysis by marker‐set kernel machine regression, 36
J. Sun, K. Oualkacha, V. Forgetta, H.‐F. Zheng, J. B. Richards, A. Ciampi (2016)
A method for analyzing multiple continuous phenotypes in rare variant association studies allowing for flexible correlations in variant effects, 24
Qianchuan He, C. Avery, D. Lin (2013)
A General Framework for Association Tests With Multivariate Traits in Large‐Scale Genomics StudiesGenetic Epidemiology, 37
Alexander Martin, M. Ochagavía, Laya Rabasa, Jamilet Miranda, J. Fernández-de-Cossio, R. Bringas (2010)
BisoGenet: a new tool for gene network building, visualization and analysisBMC Bioinformatics, 11
Z. Zhuang, C. Yang, F. Lorenzo, M. Merino, T. Fojo, E. Kebebew (2012)
Somatic hif2a gain‐of‐function mutations in paraganglioma with polycythemia, 367
Qiong Yang, Hongsheng Wu, Chao-Yu Guo, C. Fox (2010)
Analyze multivariate phenotypes in genetic association studies by combining univariate association testsGenetic Epidemiology, 34
Bing Yu, S. O'toole, R. Trent (2015)
Somatic DNA mutation analysis in targeted therapy of solid tumours.Translational pediatrics, 4 2
Jianping Sun, Jianping Sun, K. Oualkacha, Vincenzo Forgetta, Houfeng Zheng, J. Richards, A. Ciampi, C. Greenwood (2016)
A method for analyzing multiple continuous phenotypes in rare variant association studies allowing for flexible correlations in variant effectsEuropean Journal of Human Genetics, 24
P. S. Rachakonda, A. S. Bauer, H. Xie, D. Campa, C. Rizzato, F. Canzian (2013)
Somatic mutations in exocrine pancreatic tumors: association with patient survival, 8
B. Reva, Y. Antipin, C. Sander (2011)
Predicting the functional impact of protein mutations: Application to cancer genomics, 39
M. Lawrence, P. Stojanov, P. Polak, G. Kryukov, K. Cibulskis, A. Sivachenko, S. Carter, C. Stewart, C. Mermel, S. Roberts, AdamKiezun, P. Hammerman, AaronMcKenna, Y. Drier, L. Zou, A. Ramos, Trevor Pugh, Nicolas Stransky, E. Helman, Jaegil Kim, C. Sougnez, L. Ambrogio, E. Nickerson, Erica Shefler, M. Cortés, D. Auclair, G. Saksena, Douglas Voet, M. Noble, D. Dicara, Pei Lin, Lee Lichtenstein, David Heiman, T. Fennell, M. Imieliński, Bryan Hernandez, Eran Hodis, S. Baca, A. Dulak, Jens Lohr, D. Landau, Catherine Wu, J. Meléndez-Zajgla, A. Hidalgo-Miranda, A. Koren, S. Mccarroll, J. Mora, Ryan Lee, B. Crompton, R. Onofrio, Melissa Parkin, W. Winckler, K. Ardlie, S. Gabriel, C. Roberts, J. Biegel, K. Stegmaier, A. Bass, L. Garraway, M. Meyerson, T. Golub, D. Gordenin, S. Sunyaev, E. Lander, G. Getz (2014)
Mutational heterogeneity in cancer and the search for new cancer genes
A. Maity, Patrick Sullivan, Jun‐ing Tzeng (2012)
Multivariate Phenotype Association Analysis by Marker‐Set Kernel Machine RegressionGenetic Epidemiology, 36
K. Schulze, S. Imbeaud, E. Letouzé, L. B. Alexandrov, J. Calderaro, S. Rebouissou (2015)
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets, 47
Y. Ikeda, M. Shimada, H. Hasegawa, T. Gion, K. Kajiyama, K. Shirabe (1998)
Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resection, 27
I. Watson, Koichi Takahashi, Koichi Takahashi, P. Futreal, L. Chin (2013)
Emerging patterns of somatic mutations in cancerNature Reviews Genetics, 14
Y. Liu, M. Yasukawa, K. Chen, L. Hu, R. R. Broaddus, L. Ding (2015)
Association of somatic mutations of adamts genes with chemotherapy sensitivity and survival in high‐grade serous ovarian carcinoma, 1
Q. He, C. L. Avery, D.‐Y. Lin (2013)
A general framework for association tests with multivariate traits in large‐scale genomics studies, 37
R. B. Davies (1987)
Hypothesis testing when a nuisance parameter is present only under the alternative, 74
J. Sun, Y. Zheng, L. Hsu (2013)
A unified mixed‐effects model for rare‐variant association in sequencing studies, 37
Liu (2009)
A new chi-square approximation to the distribution of non-negative definite quadratic forms in non-central normal variablesComputational Statistics & Data Analysis, 53
Michael Wu, Seunggeun Lee, T. Cai, Yun Li, M. Boehnke, Xihong Lin (2011)
Rare-variant association testing for sequencing data with the sequence kernel association test.American journal of human genetics, 89 1
L. Luzzatto (2011)
Somatic mutations in cancer developmentEnvironmental Health, 10
Yijuan Hu, S. Berndt, S. Gustafsson, A. Ganna, J. Hirschhorn, K. North, E. Ingelsson, D. Lin (2013)
Meta-analysis of gene-level associations for rare variants based on single-variant statistics.American journal of human genetics, 93 2
Lawrence (2013)
Mutational heterogeneity in cancer and the search for new cancer-associated genesNature, 499
IntroductionSomatic mutations play a fundamental role in the development and progression of cancer (Luzzatto, ). Recent progress in high‐throughput genome technologies has enabled sequencing of cancer genomes in hundreds of patients (Watson et al., ), making it possible to comprehensively evaluate the health impact of somatic mutations at a large scale. The study of somatic mutations with respect to cancer‐related traits provides novel insight into tumor biology, offers new paths to drug development, and potentially leads to better clinical treatment (Yu, O'Toole, and Trent, ).A major challenge in analyzing somatic mutation data lies in the low frequency of somatic mutations. The median non‐silent mutation rate in protein‐coding regions is estimated to be 1.5/Mb (Lawrence et al., ); for a typical gene with 1000bp of coding sequence, this translates to only 1.5e‐3 non‐silent mutations per gene. Besides the low mutation rate, somatic mutations are often distributed across many different sites of the gene, hence the frequency of somatic mutation at each individual site can be extremely low; for this reason, it is nearly impossible to conduct statistical inference for a single mutation site. A common strategy to alleviate this problem is to summarize somatic mutations within a gene into a
Biometrics – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.